LEADER 01421nam  2200433   450 
001 9910707229903321
005 20160624093559.0
035   $a(CKB)5470000002463211
035   $a(OCoLC)952177529
035   $a(OCoLC)995470000002463211
035   $a(EXLCZ)995470000002463211
100   $a20160624d2011      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aMedicaid brand-name drugs $erising prices are offset by manufacturer rebates
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d2011.
215   $a1 online resource (iii, 22 pages) $cillustrations
300   $aTitle from title screen (viewed June 14, 2016).
300   $a"August 2011."
300   $a"OEI-03-10-00260."
320   $aIncludes bibliographical references.
517   $aMedicaid brand-name drugs 
606   $aMedicaid$xCosts
606   $aBrand name products$xPrices$zUnited States
606   $aDrugs$xPrices$zUnited States
606   $aPharmaceutical policy$zUnited States
615  0$aMedicaid$xCosts.
615  0$aBrand name products$xPrices
615  0$aDrugs$xPrices
615  0$aPharmaceutical policy
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910707229903321
996   $aMedicaid brand-name drugs$93461892
997   $aUNINA